Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives D Sriram, P Yogeeswari, JS Basha, DR Radha, V Nagaraja Bioorganic and medicinal chemistry 13 (20), 5774 - 5778, 2005 | 159 | 2005 |
Analysis of five HMG‐CoA reductase inhibitors—atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and … MK Pasha, S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, ... Biomedical Chromatography 20 (3), 282-293, 2006 | 149 | 2006 |
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and … SJS Basha, SA Naveed, NK Tiwari, D Shashikumar, S Muzeeb, TR Kumar, ... Journal of Chromatography B 853 (1-2), 88-96, 2007 | 61 | 2007 |
Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors S Khanna, M Madan, A Vangoori, R Banerjee, R Thaimattam, ... Bioorganic Medicinal Chemistry 14 (14), 4820 - 4833, 2006 | 55 | 2006 |
Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke JSB Shaik, M Ahmad, W Li, ME Rose, LM Foley, TK Hitchens, SH Graham, ... American journal of physiology: Heart and circulatory physiology 305 (11 …, 2013 | 54 | 2013 |
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2 J Cheng, ML Edin, SL Hoopes, H Li, JA Bradbury, JP Graves, LM DeGraff, ... FASEB J 28 (7), 2915 - 2931, 2014 | 49 | 2014 |
Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain SB Shaik, M TM, P SM, SH Graham, MD Manole Journal of chromatography. B, Analytical technologies in the biomedical and …, 2014 | 39 | 2014 |
20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac … JS Shaik, SM Poloyac, PM Kochanek, H Alexander, DL Tudorascu, ... Journal of cerebral blood flow and metabolism 35 (11), 1757–1763, 2015 | 36 | 2015 |
A phase 1 study to evaluate the pharmacokinetics and safety of cabotegravir in patients with hepatic impairment and healthy matched controls JSB Shaik, SL Ford, Y Lou, Z Zhang, KK Bakshi, AR Tenorio, C Trezza, ... Clinical pharmacology in drug development 8 (5), 664-673, 2019 | 23 | 2019 |
Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers BM Jucker, EJ Fuchs, S Lee, V Damian, P Galette, R Janiczek, KJ Macura, ... British Journal of Clinical Pharmacology 88 (4), 1655-1666, 2022 | 20 | 2022 |
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults SL Letendre, A Mills, D Hagins, S Swindells, F Felizarta, J Devente, ... Journal of Antimicrobial Chemotherapy 75 (3), 648-655, 2020 | 20 | 2020 |
Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis JS Shaik, ED Weld, S Edick, E Fuchs, S Riddler, MA Marzinke, R D'Amico, ... British journal of clinical pharmacology 88 (4), 1667-1678, 2022 | 13 | 2022 |
Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats S Muzeeb, MK Pasha, SJS Basha, R Mullangi, NR Srinivas Xenobiotica 35 (8), 825-838, 2005 | 13 | 2005 |
Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult … K Han, H Gevorkyan, J Sadik Shaik, H Crauwels, C Leemereise, ... Antimicrobial Agents and Chemotherapy 68 (1), e00781-23, 2024 | 9 | 2024 |
First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from … A Hansen, TM Bauer, V Moreno, M Maio, S Groenland, J Martin-Liberal, ... Annals of Oncology 29, viii404, 2018 | 7 | 2018 |
Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague D Nguyen, JS Shaik, G Tai, C Tiffany, C Perry, E Dumont, D Gardiner, ... British Journal of Clinical Pharmacology 88 (2), 416-428, 2022 | 6 | 2022 |
Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP … S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, NR Srinivas European journal of drug metabolism and pharmacokinetics 31, 299-309, 2006 | 5 | 2006 |
Distribution in Cerebrospinal Fluid (CSF) of Cabotegravir (CAB) and Rilpivirine (RPV) after intramuscular administration of long-acting (LA) injectable suspensions in HIV-1 … S Letendre, A Mills, D Hagins, S Swindells, F Felizarta, J DeVente, ... J Int AIDS Soc 21 (Suppl 8), 2018 | 4 | 2018 |
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade S Yadavilli, JD Waight, S Brett, M Bi, T Zhang, YB Liu, C Ellis, DC Turner, ... Cancer Research Communications 3 (8), 1564-1579, 2023 | 3 | 2023 |
A study evaluating the safety, tolerability, and pharmacokinetics of a high-concentration (CAB 400 mg/ml) cabotegravir long-acting injectable formulation following subcutaneous … P Benn, K Han, J Sievers, JS Shaik, M Warwick-Sanders, B Win, D Dorey, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 125-126, 2022 | 3 | 2022 |